Compare HUYA & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HUYA | MLAB |
|---|---|---|
| Founded | 2014 | 1982 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Industrial Machinery/Components |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 572.2M | 533.0M |
| IPO Year | 2018 | 1995 |
| Metric | HUYA | MLAB |
|---|---|---|
| Price | $2.37 | $97.40 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 1 |
| Target Price | $3.50 | ★ $94.00 |
| AVG Volume (30 Days) | ★ 724.3K | 182.2K |
| Earning Date | 05-12-2026 | 05-27-2026 |
| Dividend Yield | ★ 81.37% | 0.67% |
| EPS Growth | N/A | ★ 436.11 |
| EPS | N/A | ★ 1.21 |
| Revenue | N/A | N/A |
| Revenue This Year | $14.08 | $6.07 |
| Revenue Next Year | $6.11 | $5.41 |
| P/E Ratio | ★ N/A | $80.59 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.15 | $59.63 |
| 52 Week High | $4.93 | $113.99 |
| Indicator | HUYA | MLAB |
|---|---|---|
| Relative Strength Index (RSI) | 44.85 | 48.24 |
| Support Level | $2.15 | $94.01 |
| Resistance Level | $2.53 | $97.56 |
| Average True Range (ATR) | 0.07 | 4.54 |
| MACD | 0.01 | 0.21 |
| Stochastic Oscillator | 15.79 | 41.30 |
Huya officially became independent in 2016 and is headquartered in Guangzhou. It operates a live streaming platform focused on games, esports, and interactive entertainment, and also provides game-related services such as distribution and in-game item sales. Its main livestreaming platforms include Huya Live in China and Nimo TV outside of China. Huya is a subsidiary of Tencent, which owned 67% of its equity stake and held 95% of the voting power, as of the end of 2025.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.